Onco BCG 40 mg Injection

Get a Price/Quote

MOQ : 215 Boxes

Onco BCG 40 mg Injection Specification

Origin of Medicine
INDIA

Physical Form
Powder

Recommended For
DOCTOR

Quantity
315 Boxes

Reconstitution Solvent
0.9% sodium chloride

Administration Route
Intravesical

Brand Name
Onco BCG

Color
Off-white powder

Sterility
Sterile

Prescription Required
Yes

Strength
40 mg/vial

Onco BCG 40 mg Injection Trade Information

Minimum Order Quantity
215 Boxes

Delivery Time
1 Week

About Onco BCG 40 mg Injection

Onco BCG 40 mg Injection is an effective therapeutic option for patients diagnosed with early-stage bladder cancer, particularly for those whose tumors have not invaded the bladder muscle. This innovative vaccine functions by targeting and eliminating cancerous cells while significantly reducing the risk of cancer recurrence, thereby aiding in long-term management of the disease. Administered directly into the bladder, Onco BCG stimulates the immune system to recognize and attack malignant cells, fostering a proactive response against bladder cancer. Patients should be aware of potential side effects, including mild flu-like symptoms and bladder irritation, which may occur post-treatment. It's crucial to discuss any existing health conditions or medications with a healthcare provider before initiating therapy to ensure safety and effectiveness. With its proven efficacy, Onco BCG is a cornerstone in the fight against bladder cancer, offering hope for improved patient outcomes. Always follow your physician's instructions and attend regular follow-up appointments to monitor progress and address any concerns.

Therapeutic Application

Onco BCG 40 mg Injection is indicated for intravesical use in the treatment and prevention of bladder cancer, particularly in non-muscle invasive bladder carcinoma. When administered as directed by a healthcare provider, it helps stimulate the immune system to prevent the recurrence of tumors.

Product Handling and Reconstitution

The off-white powder form of Onco BCG Injection should be reconstituted with 0.9% sodium chloride as per the instructions provided with the product. Strict adherence to sterile techniques during preparation and administration is crucial to ensure patient safety and efficacy.

Distribution and Supply Considerations

Onco BCG is available in bulk packaging, making it suitable for distribution to hospitals and clinics through authorized distributors, exporters, suppliers, traders, and wholesalers. As a prescription-only medication, it is intended for use by licensed healthcare professionals.

FAQ's of Onco BCG 40 mg Injection:

Q: How is Onco BCG 40 mg Injection administered?

A: Onco BCG 40 mg Injection is administered intravesically, meaning it is delivered directly into the bladder by a trained healthcare provider. The reconstituted solution is instilled using a catheter under sterile conditions.

Q: What are the steps for reconstituting the Onco BCG powder?

A: To reconstitute the Onco BCG powder, use 0.9% sodium chloride as the solvent. Carefully follow sterile procedures to mix the powder until fully dissolved. The reconstituted solution should be prepared just before administration.

Q: When should Onco BCG 40 mg Injection be used?

A: This product is recommended for use as part of a prescribed treatment plan for non-muscle invasive bladder cancer. The timing and frequency of administration are determined by the treating healthcare professional according to the patient's clinical needs.

Q: Where should Onco BCG 40 mg Injection be stored?

A: The product should be stored in a cool, dry place away from direct sunlight and moisture. Always follow storage guidelines provided by the manufacturer and ensure it remains within the specified temperature range.

Q: What are the benefits of using Onco BCG Intravesical Injection?

A: Onco BCG Injection is effective in reducing the recurrence and progression of non-muscle invasive bladder cancer by stimulating the patient's immune response against tumor cells, offering a valuable adjunct to surgical intervention.